Associations of intestinal microbiota signatures with the efficacy and toxicity of chemotherapy in patients with advanced pancreatic cancer
Recruiting
- Conditions
- C25.9Pancreas, unspecified
- Registration Number
- DRKS00022201
- Lead Sponsor
- German Cancer Research Center (DKFZ)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients with locally advanced or metastatic PDAC or recurrence after primary PDAC resection who receive palliative chemotherapy based on medical indication.
- Persons who have understood the informed consent and signed the written consent form.
Exclusion Criteria
- Refusal by the patient
- Age < 18 years
- Lack of ability to consent
- Pancreas resection with (neo)adjuvant chemotherapy
- Previous treatment of other malignant cancers
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method